Literature DB >> 4096649

Effects of oxygenated derivatives of cholesterol on cholesterol uptake by cultured aortic smooth muscle cells.

S K Peng, R J Morin, P Tham, C B Taylor.   

Abstract

The cytotoxicity of oxygenated derivatives of cholesterol on the cultured cells may not only be due to their potent inhibition of cholesterol biosynthesis, but also could be related to their capability for inhibiting cholesterol uptake from exogenous sources, particularly in arterial cells, which synthesize cholesterol at a very slow rate. In cultured aortic smooth muscle cells, the most potent inhibitor of cholesterol uptake was cholestane-3 beta,5 alpha,6 beta triol, which at 100 micrograms/ml medium reduced uptake of cholesterol to 10% of the control. The next most potent inhibitors were 5 alpha,6 alpha- epoxycholesterol and 25-hydroxycholesterol, which reduced uptake of cholesterol to 60%. 7 alpha- and 7 beta-hydroxycholesterol and 7-ketocholesterol inhibited cholesterol uptake to 30-50%. A consequence of their inhibitory effects on cholesterol uptake could be a depletion of cell membrane cholesterol, resulting in alterations in membrane structure and function and eventually in cell death.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4096649

Source DB:  PubMed          Journal:  Artery        ISSN: 0098-6127


  3 in total

1.  Dietary oxysterols induce in vivo toxicity of coronary endothelial and smooth muscle cells.

Authors:  Alexandra Meynier; Agnès Andre; Jeanine Lherminier; André Grandgirard; Luc Demaison
Journal:  Eur J Nutr       Date:  2005-01-27       Impact factor: 5.614

2.  Reaction of cholesterol 5,6-epoxides with simulated gastric juice.

Authors:  G Maerker; E H Nungesser; F J Bunick
Journal:  Lipids       Date:  1988-08       Impact factor: 1.880

3.  Changes in linoleic acid metabolism and membrane fatty acids of LLC-PK cells in culture induced by 5 alpha-cholestane-3 beta,5,6 beta-triol.

Authors:  M Mahfouz; T Smith; F A Kummerow
Journal:  Lipids       Date:  1995-11       Impact factor: 1.880

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.